Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US
New Delhi: Eugia Pharma Specialities Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has launched Pomalidomide Capsules, 1 mg, 2 mg, 3 mg and 4 mg, in the US…
New Delhi: Eugia Pharma Specialities Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has launched Pomalidomide Capsules, 1 mg, 2 mg, 3 mg and 4 mg, in the US…
New Delhi: India's apex drug regulator, the Central Drugs Standard Control Organization (CDSCO), has issued a public advisory following the reported theft of a batch of the insulin product Lantus…
GLP-1s and addiction, a gene therapy company and a mining corporation, and more biotech news from The Readout
Panaji: The Goa government has blacklisted a pharmaceutical company following a controversy over the alleged supply of suspicious anti-snake venom to the Directorate of Health Services (DHS), triggering an investigation…
Hyderabad: NATCO Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide Capsules in the United States, a generic version of Pomalyst marketed by Celgene.Pomalidomide, a…
Chennai: Caplin Steriles Limited, a wholly owned subsidiary of Caplin Point Laboratories Limited, has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug…
Researchers have found in a new research that although sugar-free chewing gum does not significantly reduce orthodontic pain, it may lessen the impact of pain on oral health–related quality of…
A new study published in the journal of Frontiers in Endocrinology showed that patients with diabetic kidney disease (DKD) benefit greatly from Sodium-glucose cotransporter-2 (SGLT2) inhibitors, but there is also…
A new study published in The British Journal of Psychiatry showed that risperidone increases the risk of stroke in the individuals with dementia who have a history of cardiovascular disease…
USA: With the global rise in coronary artery disease (CAD), substantial variability in radiation doses from diagnostic tests highlights a pressing need for better training, standardized imaging protocols, and upgraded…